Interferon-gamma signaling promotes melanoma progression and metastasis

Oncogene. 2023 Jan;42(5):351-363. doi: 10.1038/s41388-022-02561-x. Epub 2022 Dec 3.

Abstract

Interferon-gamma (IFNG) has long been regarded as the flag-bearer for the anti-cancer immunosurveillance mechanisms. However, relatively recent studies have suggested a dual role of IFNG, albeit there is no direct experimental evidence for its potential pro-tumor functions. Here we provide in vivo evidence that treatment of mouse melanoma cell lines with Ifng enhances their tumorigenicity and metastasis in lung colonization allograft assays performed in immunocompetent syngeneic host mice, but not in immunocompromised host mice. We also show that this enhancement is dependent on downstream signaling via Stat1 but not Stat3, suggesting an oncogenic function of Stat1 in melanoma. The experimental results suggest that melanoma cell-specific Ifng signaling modulates the tumor microenvironment and its pro-tumorigenic effects are partially dependent on the γδ T cells, as Ifng-enhanced tumorigenesis was inhibited in the TCR-δ knockout mice. Overall, these results show that Ifng signaling may have tumor-promoting effects in melanoma by modulating the immune cell composition of the tumor microenvironment.

MeSH terms

  • Animals
  • Carcinogenesis
  • Cell Line
  • Cell Line, Tumor
  • Interferon-gamma* / metabolism
  • Melanoma* / pathology
  • Mice
  • Mice, Knockout
  • Signal Transduction
  • Tumor Microenvironment

Substances

  • Interferon-gamma